MAPT and Alzheimer disease: Another innovative method to specifically characterize AD pathology by PET imaging is through the use of selective in-vivo tau PET tracers, which allow the quantifying of tau aggregation in the brain.43,44 Neuropathological studies of AD show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes, and selective tau imaging enables these associations to be explored in vivo.